Titre : Protéines de filaments intermédiaires

Protéines de filaments intermédiaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Disorders

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Intermediate Filament Proteins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de filaments intermédiaires : Questions médicales les plus fréquentes", "headline": "Protéines de filaments intermédiaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de filaments intermédiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-03", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines du cytosquelette", "url": "https://questionsmedicales.fr/mesh/D003598", "about": { "@type": "MedicalCondition", "name": "Protéines du cytosquelette", "code": { "@type": "MedicalCode", "code": "D003598", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Desmine", "alternateName": "Desmin", "url": "https://questionsmedicales.fr/mesh/D003893", "about": { "@type": "MedicalCondition", "name": "Desmine", "code": { "@type": "MedicalCode", "code": "D003893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.200" } } }, { "@type": "MedicalWebPage", "name": "Protéine gliofibrillaire acide", "alternateName": "Glial Fibrillary Acidic Protein", "url": "https://questionsmedicales.fr/mesh/D005904", "about": { "@type": "MedicalCondition", "name": "Protéine gliofibrillaire acide", "code": { "@type": "MedicalCode", "code": "D005904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.400" } } }, { "@type": "MedicalWebPage", "name": "Kératine-15", "alternateName": "Keratin-15", "url": "https://questionsmedicales.fr/mesh/D053569", "about": { "@type": "MedicalCondition", "name": "Kératine-15", "code": { "@type": "MedicalCode", "code": "D053569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.450.300.500" } } }, { "@type": "MedicalWebPage", "name": "Vimentine", "alternateName": "Vimentin", "url": "https://questionsmedicales.fr/mesh/D014746", "about": { "@type": "MedicalCondition", "name": "Vimentine", "code": { "@type": "MedicalCode", "code": "D014746", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires", "alternateName": "Intermediate Filament Proteins", "code": { "@type": "MedicalCode", "code": "D007381", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sarah Köster", "url": "https://questionsmedicales.fr/author/Sarah%20K%C3%B6ster", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Sandrine Etienne-Manneville", "url": "https://questionsmedicales.fr/author/Sandrine%20Etienne-Manneville", "affiliation": { "@type": "Organization", "name": "Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr." } }, { "@type": "Person", "name": "Charlotta Lorenz", "url": "https://questionsmedicales.fr/author/Charlotta%20Lorenz", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Anna V Schepers", "url": "https://questionsmedicales.fr/author/Anna%20V%20Schepers", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Rudolf E Leube", "url": "https://questionsmedicales.fr/author/Rudolf%20E%20Leube", "affiliation": { "@type": "Organization", "name": "Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37354871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cortex.2023.04.016" } }, { "@type": "ScholarlyArticle", "name": "Access to Speech and Language Services and Service Providers for Children With Speech and Language Disorders.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35613324", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_AJSLP-21-00287" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic hypnosis in a child with a written language disorder.", "datePublished": "2022-10-05", "url": "https://questionsmedicales.fr/article/36197740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00029157.2022.2108746" } }, { "@type": "ScholarlyArticle", "name": "Telepractice in the diagnosis and treatment of pediatric speech-language disorders: The opinions and experiences of speech-language pathologists.", "datePublished": "2023-04-19", "url": "https://questionsmedicales.fr/article/37116275", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijporl.2023.111560" } }, { "@type": "ScholarlyArticle", "name": "Activities and participation of children with language disorders in outpatient care according to the ICF.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37556703", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232022007pt" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines du cytosquelette", "item": "https://questionsmedicales.fr/mesh/D003598" }, { "@type": "ListItem", "position": 5, "name": "Protéines de filaments intermédiaires", "item": "https://questionsmedicales.fr/mesh/D007381" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de filaments intermédiaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de filaments intermédiaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Protéines de filaments intermédiaires", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D007381?mesh_terms=Language+Disorders#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 28/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Sarah Köster

9 publications dans cette catégorie

Affiliations :
  • Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.

Sandrine Etienne-Manneville

8 publications dans cette catégorie

Affiliations :
  • Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr.

Charlotta Lorenz

6 publications dans cette catégorie

Affiliations :
  • Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.

Anna V Schepers

5 publications dans cette catégorie

Affiliations :
  • Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.

Rudolf E Leube

4 publications dans cette catégorie

Affiliations :
  • Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany.

Julia Kraxner

4 publications dans cette catégorie

Affiliations :
  • Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, D-13125 Berlin, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, D-10785 Berlin, Germany.
Publications dans "Protéines de filaments intermédiaires" :

Pierre A Coulombe

3 publications dans cette catégorie

Affiliations :
  • Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: coulombe@umich.edu.
Publications dans "Protéines de filaments intermédiaires" :

Stéphanie Portet

3 publications dans cette catégorie

Affiliations :
  • Department of Mathematics, University of Manitoba, Winnipeg, MB, Canada.

Ohad Medalia

3 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Publications dans "Protéines de filaments intermédiaires" :

Harald Herrmann

3 publications dans cette catégorie

Affiliations :
  • Institute of Neuropathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Puneet Opal

3 publications dans cette catégorie

Affiliations :
  • Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :

Stefan Klumpp

3 publications dans cette catégorie

Affiliations :
  • Institute for Dynamics of Complex Systems, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
Publications dans "Protéines de filaments intermédiaires" :

Alexander A Dayal

2 publications dans cette catégorie

Affiliations :
  • Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia.

Alexander A Minin

2 publications dans cette catégorie

Affiliations :
  • Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia. alexminin@gmail.com.

Hakan Sağsöz

2 publications dans cette catégorie

Affiliations :
  • Department of Histology and Embryology, Faculty of Veterinary Medicine, Dicle University, Diyarbakır, Turkey.
Publications dans "Protéines de filaments intermédiaires" :

J C Dallon

2 publications dans cette catégorie

Affiliations :
  • Department of Mathematics, Brigham Young University, 344 TMCB, Provo, Utah 84602-6539, USA. Electronic address: dallon@math.byu.edu.
Publications dans "Protéines de filaments intermédiaires" :

Cécile Leduc

2 publications dans cette catégorie

Affiliations :
  • Institut Pasteur Paris CNRS UMR3691, Cell Polarity, Migration and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, 25 rue du Dr Roux, Paris Cedex 15, 75724, France.
Publications dans "Protéines de filaments intermédiaires" :

John E Eriksson

2 publications dans cette catégorie

Affiliations :
  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
  • Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, 20520 Turku, Finland.
  • Euro-Bioimaging ERIC, 20520 Turku, Finland.
Publications dans "Protéines de filaments intermédiaires" :

Gerhard Wiche

2 publications dans cette catégorie

Affiliations :
  • Celica BIOMEDICAL, 1000 Ljubljana, Slovenia.
  • Department of Biochemistry and Cell Biology, Max F. Perutz Laboratories, University of Vienna, 1030 Vienna, Austria.
Publications dans "Protéines de filaments intermédiaires" :

Mark Kittisopikul

2 publications dans cette catégorie

Affiliations :
  • Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :

Sources (10000 au total)

Access to Speech and Language Services and Service Providers for Children With Speech and Language Disorders.

The purposes of this study were to (a) examine children's access to services for their speech and language disorders during their lifetimes; (b) identify any child, disorder, and family characteristic... Data from the 2012 National Health Interview Survey were used for this retrospective cohort study. Our sample included 491 children (ages 3;0-17;11 [years;months]) with speech disorders and 333 childr... Approximately 75% of children with speech and language disorders had ever received services for their difficulties. Privately insured children and children with co-occurring conditions were more likel... Most children with speech and language disorders received services. However, disparities existed by race/ethnicity, health insurance type, co-occurring diagnoses, and disorder duration (speech only). ... https://doi.org/10.23641/asha.19799389....

Telepractice in the diagnosis and treatment of pediatric speech-language disorders: The opinions and experiences of speech-language pathologists.

This prospective cross-sectional study aimed to investigate the opinions and experiences with telepractice (TP) of Dutch-speaking speech-language pathologists (SLPs) living in the Dutch-speaking part ... Twenty-nine Dutch-speaking speech-language pathologists living in Flanders (age category 20-30 years: n = 16/29, 55.2%, 31-40 years: n = 10/29, 34.2%, 41-50 years: n = 2/29, 6.9%, 51-60 years: n = 1/2... The study showed a statistically significant association between years of clinical experience of SLPs and their opinion that TP does not provide more options in a clinical setting compared to face-to-... Expertise in multiple domains of pediatric speech-language therapy resulted in experiencing more added value of TP during the corona pandemic, possibly because of the experience of multiple different ...

Activities and participation of children with language disorders in outpatient care according to the ICF.

To identify the main categories of the Activities and Participation component of the International Classification of Functioning, Disability, and Health and to verify the association with age, gender,... This is an analytical and cross-sectional observational study, carried out with secondary data from 32 medical records of children with the majority male, mean age of 41.03 months, in early childhood ... The descriptive analysis of the pre-selected categories allowed us to verify a high number of "Not informed" answers, with a higher percentage in vocal expression without speech (d331) performance (93... Difficulties were identified in several categories of the Activities and Participation component and statistically significant associations between them and sociodemographic data and speech therapy di...

The Relationship Between Speech and Language Disorders and Working Memory: Children with Attention Deficit and Hyperactivity Disorder and Typical Development.

To examine the speech, language, and communication skills of school-age children with attention deficit and hyperactive disorder.... The sample of the study consists of attention deficit and hyperactivity disorder (... SPSS program was used in the analysis of the data. Mann Whitney... It has been concluded that language, speech, and working memory skills of children with attention deficit and hyperactivity disorder are lower than their peers with typical development. Speech and lan...

Distinct reinforcement learning profiles distinguish between language and attentional neurodevelopmental disorders.

Theoretical models posit abnormalities in cortico-striatal pathways in two of the most common neurodevelopmental disorders (Developmental dyslexia, DD, and Attention deficit hyperactive disorder, ADHD... Our results show that, relative to neurotypicals, DD individuals showed an impairment in model-free but not in model-based learning, whereas in ADHD the ability to use both model-free and model-based ... Thus, learning impairments in DD may be linked to a selective deficit in the ability to form action-outcome associations based on previous history, whereas in ADHD some learning deficits may be relate...

Language disorder and internalizing mental health problems in youth offenders: A systematic review.

The prevalence of language disorder in youth offenders far exceeds rates reported in community samples. Youth involved in the justice system are also at increased risk of a range of psychiatric disord... To explore the co-occurrence of language disorder and anxiety and depression in youth offenders.... A systematic literature search of six databases (CINAHL, ERIC, Medline, PyscINFO, PubMED, Scopus) was conducted (September 2021) using key search terms relevant to the systematic review question. Stud... Eight studies met the eligibility criteria. A range of measures was used to assess language abilities across samples. Only two studies directly addressed the relationship between language disorder and... Although the results did not support a significant relationship between language disorder and internalizing mental health problems in youth offenders, the two appear to occur comorbidly as evidenced b... What is already known on this subject The markedly high rates of language disorder in youth involved in the justice system have been widely reported. It is also known that externalizing mental health ...

ICF and perception of functioning according to children/adolescents in follow-up with speech/language disorders.

To characterize changes in the functioning aspects, in the perception of children and adolescents with speech and language disorders under speech-language follow-up, using the ICF.... Descriptive, analytical and longitudinal research, with a qualitative and quantitative approach, whose sample consisted of 60 children and adolescents: 30 with speech and language disorders and 30 wit... The use of ICF allowed characterizing changes resulting from speech-language follow-up. Participants with speech and language disorders presented a decrease in the magnitude of the qualifiers in the c... The findings show changes in components of Body Functions, Activities and Participation, and the influence of Environmental Factors after speech-language follow-up, in the perception of the studied gr...

Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population based cohort study.

To evaluate the association between antibiotic use during pregnancy or early infancy and the risk of neurodevelopmental disorders in children.... Nationwide population based cohort study and sibling analysis.... Korea's National Health Insurance Service mother-child linked database, 2008-21.... All children live born between 2009 and 2020, followed up until 2021 to compare those with and without antibiotic exposure during pregnancy or early infancy (first six months of life).... Autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children. After 1:1 propensity score matching based on many potential confounders, hazard ratios with 95% confidence... After propensity score matching, 1 961 744 children were identified for the pregnancy analysis and 1 609 774 children were identified for the early infancy analysis. Although antibiotic exposure durin... In this large cohort study, antibiotic exposure during pregnancy or early infancy was not associated with an increased risk of autism spectrum disorder, intellectual disorder, or language disorder in ...